Published in Int J Radiat Oncol Biol Phys on May 01, 2004
Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg (2009) 1.16
Skull base inverted papilloma: a comprehensive review. ISRN Surg (2012) 0.96
Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management. Eur Arch Otorhinolaryngol (2014) 0.87
Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes. Radiat Oncol (2006) 0.87
Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution. Skull Base (2011) 0.84
Management of sinonasal tumors: prognostic factors and outcomes: a 10 year experience at a tertiary care hospital. Indian J Otolaryngol Head Neck Surg (2013) 0.84
Lymphoepithelial carcinoma in the maxillary sinus: a case report. J Med Case Rep (2012) 0.82
The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus. Eur Arch Otorhinolaryngol (2013) 0.81
Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation. J Hematol Oncol (2013) 0.79
Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies. J Radiat Res (2012) 0.78
The importance of early diagnosis in patients with maxillary sinus carcinoma. Eur Arch Otorhinolaryngol (2015) 0.78
Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up. Int J Clin Oncol (2014) 0.76
Neoadjuvant intra-arterial chemotherapy combined with radiotherapy and surgery in patients with advanced maxillary sinus cancer. Radiat Oncol J (2013) 0.75
Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review. Oncol Lett (2015) 0.75
Locally advanced paranasal sinus carcinoma: A study of 30 patients. Oncol Lett (2017) 0.75
Paranasal sinuses malignancies: A 12-year review of clinical characteristics. Med Oral Patol Oral Cir Bucal (2016) 0.75
Robotic stereotactic radiosurgery in patients with nasal cavity and paranasal sinus tumors. Technol Cancer Res Treat (2013) 0.75
The role of radiotherapy in the management of sinonasal melanoma and its impact on patients and healthcare professionals. Eur Arch Otorhinolaryngol (2013) 0.75
Comparison of endoscopic and external resections for sinonasal instestinal-type adenocarcinoma. Eur Arch Otorhinolaryngol (2016) 0.75
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med (2004) 9.55
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 4.13
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98
p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol (2010) 3.37
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys (2004) 3.21
Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2003) 2.95
Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys (2010) 2.48
HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol (2009) 2.08
PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS. Retina (2015) 2.01
High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol (2011) 2.00
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys (2002) 1.85
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg (2003) 1.76
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.70
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol (2009) 1.66
Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys (2007) 1.65
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.65
Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys (2003) 1.65
Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg (2011) 1.64
Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys (2004) 1.64
Potential of tomotherapy for total scalp treatment. Int J Radiat Oncol Biol Phys (2002) 1.64
Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck (2007) 1.60
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res (2006) 1.52
Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy (2011) 1.50
Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys (2005) 1.47
Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer (2004) 1.43
Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys (2002) 1.42
Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys (2005) 1.42
CT localization of axillary lymph nodes in relation to the humeral head: significance of arm position for radiation therapy planning. Radiother Oncol (2005) 1.38
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope (2009) 1.37
Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys (2012) 1.35
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol (2006) 1.33
IMRT treatment planning based on prioritizing prescription goals. Phys Med Biol (2007) 1.32
Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol (2006) 1.28
Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys (2008) 1.26
Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology (2012) 1.25
Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer (2003) 1.24
Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head Neck (2006) 1.18
The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. Int J Radiat Oncol Biol Phys (2002) 1.18
Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys (2011) 1.16
Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner. Int J Radiat Oncol Biol Phys (2011) 1.16
Analysis of treatment results for oral tongue cancer. Laryngoscope (2002) 1.14
A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer (2012) 1.11
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys (2004) 1.11
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models. Clin Cancer Res (2006) 1.09
Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg (2011) 1.07
Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med (2006) 1.07
Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol (2011) 1.07
B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck Pathol (2012) 1.05
Postoperative radiation therapy for grade II and III intracranial ependymoma. Int J Radiat Oncol Biol Phys (2005) 1.03
A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys (2008) 1.02
Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head and neck cancer. Am J Clin Oncol (2006) 1.02
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncol (2008) 1.02
Long term outcome with post-operative radiation therapy for spinal canal ependymoma. J Neurooncol (2007) 1.00
Role of fusion in radiotherapy treatment planning. Semin Nucl Med (2003) 1.00
Analysis of treatment results for base of tongue cancer. Laryngoscope (2003) 0.99
Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer. Cancer (2010) 0.99
Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol (2012) 0.98
The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys (2009) 0.98
Automatic shape-based level set segmentation for needle tracking in 3-D TRUS-guided prostate brachytherapy. Ultrasound Med Biol (2012) 0.98
Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol (2011) 0.98
Survival following gamma knife radiosurgery for brain metastasis from breast cancer. Radiat Oncol (2013) 0.96
A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma. Am J Surg Pathol (2014) 0.95
Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head Neck (2010) 0.95
Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg (2012) 0.94
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys (2003) 0.94
A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma. Cancer (2012) 0.94
Current imaging paradigms in radiation oncology. Radiat Res (2005) 0.93
Potentiation of the immunotherapeutic effect of autologous dendritic cells by pretreating hepatocellular carcinoma with low-dose radiation. Clin Invest Med (2008) 0.93
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.93
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer (2003) 0.92
Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Childs Nerv Syst (2006) 0.92
Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope (2005) 0.92
Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck (2010) 0.92
Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys (2010) 0.92
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat (2010) 0.91
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life. Cancer (2014) 0.91
Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer (2008) 0.91
Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med (2004) 0.90
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev (2007) 0.90
Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Semin Radiat Oncol (2004) 0.90
Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib. J Clin Oncol (2012) 0.89
Evolution of computerized radiotherapy in radiation oncology: potential problems and solutions. Int J Radiat Oncol Biol Phys (2008) 0.89
Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer (2008) 0.89
Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival. Am J Surg Pathol (2014) 0.89
Benign causes of increased serum CA-125 concentration. Lancet Oncol (2007) 0.89
Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review. Pharmacotherapy (2002) 0.88
Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. PLoS One (2012) 0.88
Imaging response in malignant glioma, RTOG 90-06. Am J Clin Oncol (2007) 0.88
Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells. Immunopharmacol Immunotoxicol (2009) 0.87
Interobserver variation in cervical cancer tumor delineation for image-based radiotherapy planning among and within different specialties. J Appl Clin Med Phys (2005) 0.87
Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol (2005) 0.87
PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol (2005) 0.87
Targeting the hedgehog pathway to mitigate treatment resistance. Cell Cycle (2007) 0.86
Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2002) 0.86
Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status. Hum Pathol (2013) 0.86
Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers. Am J Surg Pathol (2012) 0.86